FB Pixel no scriptBiotechnology | KrASIA
MENU
KrASIA

Biotechnology

News

Hengrui weighs Hong Kong IPO to drive the next phase of global expansion

A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

4 mins read
  • Founder Wu Zhenhua explores the promise of gene therapy and its potential to reshape the future of medicine.

    Features

    Can gene therapy live up to the hype? A look at China’s Exegenesis Bio

    3 mins read

Most Recent

See All